Mrv1909 12041923282 d 11 11 0 0 0 0 999 V2000型-0.3572 -1.2374 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.0716 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0716 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3572 0.4125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.3572 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3572 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0717 -1.2374 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.0717 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7861 0.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.0717 1.2374 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.7861 0.4125 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 2 0 0 0 0 3 1 0 0 0 0 4 5 1 2 0 0 0 0 5 6 6 0 0 0 0 1 2 0 0 0 0 1 0 0 0 0 5 6 7 8 1 0 0 0 0 8 9 1 0 0 0 0 8 11 10 2 0 0 0 0 3 1 0 0 0 0 M >结束
DB12466 >
drugbank >
数控数控(F) (= O) C1 = = CN = C1O >
InChI = 1 s / C5H4FN3O2 c6-2-1-8-5 (11) 3 (9 - 2) 4 (7) 10 / h1H (H2 7 10) (H, 8、11) >
ZCGNOVWYSGBHAU-UHFFFAOYSA-N >
C5H4FN3O2 >
157.104 >
157.028754544 >
4 >
15 >
12.123878906367722 >
1 >
2 >
0 >
0 >
6-fluoro-3-hydroxypyrazine-2-carboxamide >
0.49 >
0.25191639600000004 >
-1.26 >
0 >
1 >
0 >
13.579307723139335 >
9.39401731404919 >
-3.6791532864267253 >
89.1 >
33.9761 >
1 >
1 >
8.70 e + 00 g / l >
[(2 r, 3 s 4 r 5 r) 5 - (4-amino-5-methyl-2-oxopyrimidin-1-yl) 3, 4-dihydroxyoxolan-2-yl] methoxyphosphonic酸>
0 >
DB12466 >
DB06046;DB15625 >
批准;临床实验的>
Favipiravir >
Fapilavir;Favilavir;Favipiravir >
Avigan $ $ $ $